RBC Capital analyst Drew McReynolds downgrades Shaw Comms (TSX:SJR) from Outperform to Sector Perform and announces C$40.5 price target.
Organigram Invests In Phylos Bioscience To Commercialize THCV And Scale Seed Based Production
Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has reached agreement with Phylos Bioscience Inc., to initiate a wide-ranging technical and commercial relationship in Canada.